Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model.
Animals
Depression
/ chemically induced
Disease Models, Animal
Disks Large Homolog 4 Protein
/ metabolism
Hippocampus
/ metabolism
Interferon-alpha
Mice
Neuronal Plasticity
/ physiology
Neurons
/ metabolism
Poly I-C
Signal Transduction
/ physiology
Toll-Like Receptor 3
/ metabolism
Vesicular Glutamate Transport Protein 1
/ metabolism
Dendritic plasticity
Major depressive disorder
Neuronal depolarization
Neuronal plasticity
Patch clamp recording
Synaptic plasticity
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
27
09
2019
accepted:
01
05
2020
pubmed:
7
6
2020
medline:
20
5
2021
entrez:
7
6
2020
Statut:
ppublish
Résumé
Disrupted neuronal plasticity due to subtle inflammation is considered to play a fundamental role in the pathogenesis of major depressive disorder. Interferon-α (IFN-α) potentiates immune responses against viral pathogens that induce toll-like receptor-3 (TLR3) activation but evokes severe major depressive disorder in humans by mechanisms that remain insufficiently described. By using a previously established mouse model of depression induced by combined delivery of IFN-α and polyinosinic:polycytidylic acid (poly(I:C)), a TLR3 agonist, we provide evidence that IFN-α and poly(I:C) reduce apical dendritic spine density in the hippocampal CA1 area ex vivo via mechanisms involving decreased TrkB signaling. In vitro, IFN-α and poly(I:C) treatments required neuronal activity to reduce dendritic spine density and TrkB signaling. The levels of presynaptic protein vesicular glutamate transporter (VGLUT)-1 and postsynaptic protein postsynaptic density-95 (PSD95) were specifically decreased, whereas the expression of both synaptic and extrasynaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 1 (AMPAR1) was increased by IFN-α and poly(I:C) delivery. Patch clamp recordings in primary hippocampal neurons revealed that morphological changes at the synapse induced by IFN-α and poly(I:C) costimulation were accompanied by an increased action potential threshold and action potential frequency, indicative of impaired neuronal excitability. Taken together, IFN-α and poly(I:C) delivery leads to structural and functional alterations at the synapse indicating that compromised neuroplasticity may play an integral role in the pathogenesis of immune response-induced depression.
Identifiants
pubmed: 32504419
doi: 10.1007/s12035-020-01927-0
pii: 10.1007/s12035-020-01927-0
pmc: PMC7320059
doi:
Substances chimiques
Disks Large Homolog 4 Protein
0
Dlg4 protein, mouse
0
Interferon-alpha
0
Toll-Like Receptor 3
0
Vesicular Glutamate Transport Protein 1
0
Poly I-C
O84C90HH2L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3171-3182Subventions
Organisme : German Research Foundation
ID : HE-3173/3-1
Références
J Neurochem. 2006 Aug;98(3):939-50
pubmed: 16893425
J Neurosci. 2012 Mar 21;32(12):3992-4003
pubmed: 22442066
Science. 2004 Jun 18;304(5678):1815-9
pubmed: 15118123
Front Cell Neurosci. 2014 Apr 01;8:87
pubmed: 24744698
Hippocampus. 2013 Aug;23(8):696-707
pubmed: 23554175
J Cell Biol. 2018 Aug 6;217(8):2727-2742
pubmed: 29777026
Neuroimmunomodulation. 2000;7(3):153-9
pubmed: 10754403
Curr Top Behav Neurosci. 2011;7:121-47
pubmed: 21225412
Neuron. 2009 Nov 25;64(4):463-70
pubmed: 19945389
Nat Med. 2017 Jun;23(6):714-722
pubmed: 28504723
Mol Brain. 2012 Jun 09;5:22
pubmed: 22681877
Brain Behav Immun. 2013 Feb;28:170-81
pubmed: 23201589
Brain Behav Immun. 2014 Nov;42:222-31
pubmed: 25066466
Alzheimers Dement. 2016 Dec;12(12):1273-1287
pubmed: 27327541
J Neurochem. 2012 Jul;122(1):58-71
pubmed: 22533963
Glia. 2005 Nov 1;52(2):153-62
pubmed: 15920723
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E526-35
pubmed: 23345427
EMBO Rep. 2017 Jan;18(1):169-183
pubmed: 27979975
Int J Clin Pract. 2014 Feb;68(2):255-61
pubmed: 24372654
Transl Psychiatry. 2017 Feb 21;7(2):e1038
pubmed: 28221365
Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S203-6
pubmed: 14677080
Int J Mol Sci. 2017 Jan 28;18(2):
pubmed: 28134845
Neuropharmacology. 2018 Jun;135:1-10
pubmed: 29505789
Neuropsychopharmacology. 2016 Sep;41(10):2502-11
pubmed: 27067128
Front Cell Neurosci. 2015 Jan 28;9:5
pubmed: 25674053
Channels (Austin). 2012 Jan-Feb;6(1):60-4
pubmed: 22373567
Mol Neurobiol. 2015 Aug;52(1):318-29
pubmed: 25159480
Neural Plast. 2016;2016:5214961
pubmed: 26881114
Eur Neuropsychopharmacol. 2013 Oct;23(10):1165-81
pubmed: 23332457
Stem Cell Reports. 2014 Jun 26;3(1):73-84
pubmed: 25068123
PLoS One. 2019 Apr 15;14(4):e0215554
pubmed: 30986274
PLoS One. 2013 Dec 31;8(12):e83149
pubmed: 24391741
Int J Neuropsychopharmacol. 2011 Mar;14(2):247-53
pubmed: 20667172
Brain Res. 2000 Dec 1;885(1):14-24
pubmed: 11121525
Sci Rep. 2016 Jan 08;6:19106
pubmed: 26742695
J Interferon Cytokine Res. 2015 Apr;35(4):317-24
pubmed: 25517826
Psychol Med. 2014 Mar;44(4):789-95
pubmed: 23659574
Neuropharmacology. 2012 Jan;62(1):63-77
pubmed: 21827775
Brain Behav Immun. 2016 Jul;55:25-38
pubmed: 26408796